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Abstract For targeting and integration of proteins into the
mammalian endoplasmic reticulum, two types of signals can be
distinguished: those that translocate their C-terminal sequence
(cleavable signals and signal-anchors) and those that translocate
their N-terminus (reverse signal-anchors). In addition to the well
established effect of flanking charges, also the length and
hydrophobicity of the apolar core of the signal as well as protein
folding and glycosylation contribute to orienting the signal in the
translocon. In multi-spanning membrane proteins, topogenic
determinants are distributed throughout the sequence and may
even compete with each other. During topogenesis, segments
of up to 60 residues may move back and forth through the
translocon, emphasizing unexpected dynamic aspects of topo-
genesis. ß 2001 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Signals translocate either their C- or N-terminus
In mammalian cells, protein targeting to the endoplasmic
reticulum (ER) is mostly cotranslational [1], i.e. protein trans-
location and membrane insertion are coupled to protein syn-
thesis. As a hydrophobic signal sequence emerges from the
ribosome, it is recognized by a signal recognition particle
(SRP) in the context of the nascent chain^ribosome complex.
This complex is targeted to the ER membrane by binding to
the SRP receptor (SR). The signal sequence then interacts
with the Sec61K subunit of the translocon [2,3] and initiates
translocation of the polypeptide. Synchronization of transla-
tion with membrane targeting and insertion prevents the pro-
tein from premature folding or aggregation in the cytosol.
This applies particularly to membrane proteins: even in sys-
tems where posttranslational targeting and translocation of
secretory proteins are common, as in Escherichia coli or yeast,
most membrane proteins and particularly the multi-spanning
ones are targeted to the membrane in an SRP-dependent man-
ner and are thus inserted cotranslationally [4].
The mammalian translocon consists of three to four copies
of the heterotrimeric Sec61 KLQ complex forming a gated pore
[5]. By cross-linking studies, TRAM (translocating chain-as-
sociating membrane protein) was shown to be in contact with
signal sequences and transmembrane segments early during
translocation and to be required for e⁄cient insertion of at
least some substrate proteins. In addition, homologues of the
yeast Sec62/63 complex have been identi¢ed [6,7]. By its
J-domain, Sec63 recruits the lumenal chaperone BiP to the
translocon where it may contribute to sealing the pore and/
or translocation [8]. This machinery is responsible for the
translocation of secretory proteins and the membrane inser-
tion of the vast majority of membrane proteins.
Single-spanning membrane proteins may assume a ¢nal
topology with a cytoplasmic N- and an exoplasmic C-termi-
nus (Ncyt/Cexo) or with the opposite orientation (Nexo/Ccyt).
However, if the mechanism of insertion is taken into consid-
eration, four major types of single-spanning membrane pro-
teins can be distinguished, as is summarized in Table 1. Type I
membrane proteins are initially targeted to the ER by an
N-terminal, cleavable signal sequence, a hydrophobic stretch
of typically 7^15 predominantly apolar residues, and then an-
chored in the membrane by a subsequent stop-transfer se-
quence, a segment of V20 hydrophobic residues that halts
the further translocation of the polypeptide and acts as a
transmembrane anchor. In type II membrane proteins, a sig-
nal-anchor sequence is responsible for both insertion and an-
choring. Signal-anchor sequences are generally longer than
cleaved signals (V18^25 mostly apolar amino acids), since
they span the lipid bilayer as a transmembrane helix. They
lack a signal peptidase cleavage site and they can be posi-
tioned internally within the polypeptide chain. However, like
cleaved signals, they induce the translocation of their C-ter-
minal end across the membrane. The opposite is the case for
reverse signal-anchors of type III proteins, which translocate
their N-terminal end across the membrane. These three types
of membrane proteins are all inserted by the same machinery
involving SRP, SRP receptor and the Sec61 translocon [9].
With respect to topogenesis, there are two basic types of sig-
nals translocating either their C-terminus (cleaved signals and
signal-anchors) or their N-terminus (reverse signal-anchors),
illustrated in Fig. 1.
In addition, there is also a class of proteins predominantly
exposed to the cytosol and anchored to the membrane by a
very C-terminal signal sequence. Examples are cytochrome b5
and the SNARE proteins like synaptobrevin. Insertion of
these proteins is necessarily posttranslational, since the signal
emerges from the ribosome only after translation has reached
the stop codon. Accordingly, targeting and insertion was
found to be independent of SRP and the Sec61 complex,
and to use an as yet unknown ATP-requiring mechanism
[10^12]. This last group of proteins will not be further con-
sidered here.
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2. Multiple determinants of signal sequence orientation in the
membrane
2.1. Flanking charges
The best established determinant of signal orientation (and
also so far the most useful one for topology prediction) is the
distribution of charged residues near the hydrophobic core of
signal and transmembrane segments. The ‘positive-inside rule’
was ¢rst discovered for bacterial proteins where positive res-
idues were statistically found to be four times more abundant
in cytoplasmic than in periplasmic loops [13]. An opposite,
but weaker correlation exists for acidic amino acids. A similar
charge bias was also observed for membrane proteins in the
ER, chloroplasts and mitochondria [14,15]. For ER signals,
the charge di¡erence between the two £anking segments of a
signal’s hydrophobic core, rather than the positive charge per
se correlates with transmembrane orientation: the more pos-
itive £anking sequence is generally cytoplasmic [16]. Experi-
mentally, a type III cytochrome P-450 could be converted to a
type II protein by insertion of positively charged residues into
its short N-terminal domain [17^19]. Mutation of £anking
charges in the asialoglycoprotein (ASGP) receptor H1 and
in the paramyxovirus hemagglutinin neuraminidase, two
type II proteins, caused a fraction of the polypeptides to insert
with the opposite type III topology (Fig. 2A) [20^22]. How-
ever, since in these as well as other studies (e.g. [23,24]) the
asymmetric distribution of £anking charges in mutant pro-
teins was not su⁄cient to generate a unique topology, it is
clear that additional factors must contribute to uniform topo-
genesis.
Charged residues near the hydrophobic core of a signal are
likely to exert their topogenic e¡ect by interaction with neg-
ative charges at the cytoplasmic and/or positive charges at the
exoplasmic sides of the translocon. As yet, no relevant
charged residues have been identi¢ed in the proteins of the
translocation machinery. In the bacterial system, there is evi-
dence for an electrostatic interaction of positive £anking
charges with negative lipids on the cytosolic membrane sur-
face, resulting in retention of the positive portion on the cy-
toplasmic face of the membrane [25,26]. An interaction of the
Fig. 1. Signals translocate either their C- or their N-terminus. Sig-
nal-anchor and reverse signal anchor sequences engage with the
translocon in opposite orientations resulting in type II or type III
membrane proteins, respectively. Cleavable signals behave like sig-
nal-anchors until cleavage releases the C-terminal domain into the
ER lumen (not indicated). The know determinants of signal orienta-
tion are listed above. The signals may reorient within the translo-
con.
Table 1
Topogenic determinants of single-spanning membrane proteins
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£anking sequences with lipids in or near the translocon cannot
be excluded for the eukaryotic system either.
2.2. Folding of the N-terminal domain
Cotranslational translocation ensures the direct transfer of
sequences downstream of cleavable signals and signal-anchors
across the membrane and prevents exposition to and folding
in the cytosol. (An exception is the ‘paused’ translocation
shown in translocation of apolipoprotein B which allowed
sequences to loop into the cytosol [27].) In contrast, sequences
N-terminal to an internal signal are exposed to the cytosol
before the targeting signal emerges from the ribosome. Fold-
ing of these domains may thus a¡ect their translocation com-
petence and favor retention of the N-terminus in the cytosol.
This was indeed demonstrated using mutants of the ASGP
receptor (Fig. 2). The ASGP receptor is a type II membrane
protein with a typical charge distribution: two N-terminal
arginines and two C-terminal aspartates £ank the signal se-
quence. Inversion of these charges yielded equal fractions with
each orientation (construct A [20]). Additional truncation of
the N-terminal domain allowed almost complete N-terminal
translocation (B), whereas the full coding sequence of dihy-
drofolate reductase (C) or a small zinc ¢nger domain (E)
fused at the N-terminus hindered or even blocked it [28].
This was due to protein folding and not simply the size of
the N-terminal extensions, since disruption of their structure
by destabilizing point mutations (D and F) largely recovered
N-terminal transport across the membrane. These results con-
¢rmed that the polypeptide chain needs to be unfolded for
translocation and that the folding properties of the N-termi-
nal domain in£uence protein orientation.
Many type III proteins lack a sizeable N-terminal domain,
facilitating transfer of the N-terminus. For example, most
members of the cytochrome P-450 family have just a few N-
terminal residues to translocate. In contrast, NTAK protein
(neural- and thymus-derived activator for ErbB kinases) and
the neuregulin precursor translocate N-terminal sequences of
405 and 241 residues, respectively, including immunoglobulin-
like and EGF-like domains. These sequences apparently do
not stably fold during the time they are exposed to the cyto-
sol. They are likely to be associated with cytosolic chaperones
until translocation. In addition, disul¢de formation, which
stabilizes these domains, will only occur when they have
reached the ER lumen.
2.3. Hydrophobicity
A topogenic contribution of the hydrophobic segment of
signal and signal-anchor sequences was ¢rst suggested by in
vitro experiments by Omura and colleagues. Short deletions
within the hydrophobic segment of the Nexo/Ccyt signal-an-
chor sequence of a cytochrome P-450 resulted partially in
translocation of the C-terminal reporter sequence [29]. Simi-
larly, an arti¢cial signal sequence of 12 or fewer leucines with
a negative N-terminal net charge was found to translocate its
C-terminal reporter sequence. However, with longer hydro-
phobic segments of 13 or 15 leucines a fraction of the poly-
peptides was anchored in microsomal membranes as type III
proteins [30]. Mutations which extend the hydrophobic core
of the cleaved signal of the pseudorabies virus glycoprotein gC
were observed to reduce C-terminal translocation, suggesting
that there is a limit to hydrophobicity of a cleavable export
signal [31]. Likewise, arti¢cial signals with hydrophobic cores
of 5^20 leucine residues were found to be recognized with
increasing a⁄nity by SRP (as judged by SRP-induced trans-
lation arrest in the absence of microsomal membranes). Yet,
translocation of the downstream sequence decreased with
more than 14 leucines [32]. The possibility of membrane in-
sertion in an Nexo/Ccyt orientation, however, had not been
tested in either study.
Systematic analysis of the e¡ects of di¡erent hydrophobic
domains on orienting a signal sequence in vivo was performed
using the ASGP receptor as a model protein. It was initially
observed that the receptor with a truncated N-terminal do-
main and with a generic Leu19 sequence replacing the natural
19-residue hydrophobic core of the signal-anchor (Fig. 2, con-
struct H) did not translocate the C-terminus in one third of
the products [33]. These polypeptides were shown to be in-
serted as type III proteins, since alkaline and mild saponin
extraction did not release them from the membrane, and pro-
tease protection assays con¢rmed the cytoplasmic exposition
of the C-terminus. Extending the oligo-leucine sequence up to
25 residues and thus increasing the total hydrophobicity grad-
ually increased the fraction of Nexo/Ccyt proteins to V80%
with Leu25, whereas stretches of 16 or less leucines almost
exclusively yielded type II proteins (constructs J and I, respec-
tively).
N-Terminal translocation was induced by long oligo-leucine
sequences despite a typical type II charge distribution with
two positive £anking charges at the N- and two negative
ones at the C-terminus. Reduction of the N-terminal charge
from +2 to +1 facilitated N-terminal translocation. As a re-
sult, the oligo-leucine series covered the entire spectrum from
almost complete C-terminal translocation with Leu7 to exclu-
sive N-terminal translocation with Leu22 and Leu25. In the
presence of the wild-type N-terminal domain of 40 residues,
oligo-leucine sequences did not alter type II insertion, except
Fig. 2. Multiple determinants de¢ne the orientation of ASGP recep-
tor mutants. The sequence of the ASGP receptor and various deriv-
atives are shown schematically, with a black box indicating the hy-
drophobic core of the internal signal sequence. DHFR and ZF
denote the fused sequences of mouse dihydrofolate reductase and
the yeast zinc ¢nger domain ADR1a. Point mutations a¡ecting pro-
tein folding are indicated by Xs. The black box represents the hy-
drophoic core of the signal-anchor sequence, the white box generic
oligo-leucine sequences of 19 (G, H), 16 (I), or 25 leucines (J). The
constructs were expressed in vivo in transfected COS cells. The ratio
of type II:type III insertion is listed for the constructs with the
wild-type distribution of charges £anking the signal-anchor (positive
v(N3C), left column) and with inverted £anking charges (negative
v(N3C), right column). *A fraction of the products (the di¡erence
to 100%) was not inserted into the membrane. References: A, B
[20]; C^F [28]; G, H [33].
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in combination with inverted £anking charges (Fig. 2, con-
struct G). The in£uence of the hydrophobic sequence on
topology was thus additive with the e¡ects of £anking charges
and of an N-terminal hydrophilic extension [33,34]. This may
explain how those natural signal sequences which violate the
charge rules succeed in acquiring their correct and uniform
orientation. Experimentally, this could be shown by extending
the apolar sequence of the cleavable signal of the vasopressin
precursor (v(N3C) =33) and by shortening that of the re-
verse signal-anchor of microsomal epoxide hydrolase
(v(N3C) = +3). In both cases, a signi¢cant fraction of mutant
polypeptides inserted in the opposite orientation to that of the
wild-type proteins, demonstrating the physiological signi¢-
cance of the topogenic contribution of the hydrophobic seg-
ment [35].
It is not trivial to separate the potential topogenic e¡ects of
hydrophobicity, length, and other properties of the signal
core, such as helix propensity and shape. Homo-oligomers
of other apolar sequences than oligo-leucines showed a similar
bias for increasing N-terminal translocation with increasing
length [36]. For example Val16 to Val25 sequences in the con-
text of ASGP receptor without N-terminal domain and with
an N-terminal charge of +1 covered the spectrum from unique
Ncyt/Cexo to exclusive Nexo/Ccyt insertion. The ability of di¡er-
ent homo-oligomers to promote N-terminal translocation de-
creased in the order IsLsVVWsYsFsM. Except for
oligo-alanine, which was not functional as a signal sequence,
all homo-oligomers tested were e⁄cient in targeting and in-
sertion, highlighting the ability of both SRP and the trans-
locon to accommodate an extremely broad spectrum of signal
sequences. Sequences as di¡erent in shape and volume as
Val19 and Trp19 (Fig. 3) behaved even identically with respect
to topogenesis.
In a more natural setting, all uncharged amino acids have
also been tested for their e¡ect on signal orientation in a host^
guest approach: two ‘guest residues’ of each type were in-
serted into an oligo-leucine ‘host sequence’ with a total of
16 or 19 residues in the context of N-terminally truncated
ASGP receptor [36]. Leucine is the most abundant amino
acid in transmembrane and signal sequences, accounting for
V25% of the residues. The ranking order of the amino acids
with respect to promoting N-terminal translocation was sim-
ilar to that of the homo-oligomers: IsVsLVWs
FsYsCsMsAsTs SsGsNsQsHsP. This rank-
ing resembles a hydrophobicity scale, but also a scale of helix
propensities in an apolar environment [37]. Harley et al. [34]
also observed a correlation between signal orientation and a
hydropathy gradient along the apolar sequence: the more
hydrophobic end was more e⁄ciently translocated across the
membrane.
2.4. A hypothesis for the hydrophobic contribution to
topogenesis
The signal is ¢rst bound to SRP in a hydrophobic groove
formed by the methionine-rich domain of subunit SRP54 [38],
then it is recognized by the Sec61 translocation complex [39].
By photocross-linking, it was found in contact with Sec61K
and lipids [3,40]. The hydrophobic segment of the signal was
found to speci¢cally associate with transmembrane helices 2
and 7 of Sec61p, the yeast homologue of Sec61K [41]. In
addition, TRAM could also be cross-linked to signal sequen-
ces [2,42^44].
How do the properties of the hydrophobic domain in£uence
topogenesis? The e¡ect of a hydrophobicity gradient in the
signal could be explained by a similar gradient in the signal
binding site of the translocon. However, it is more di⁄cult to
rationalize how uniform sequences like Leu19, Val19, and
Phe19 select di¡erent preferred orientations. In the apolar
binding sites of SRP and of the translocon, the hydrophobic
core of the signal is likely to assume a helical conformation. It
is not known how the signal is transferred from the ¢rst bind-
ing site to the second, except that GTP is hydrolyzed in both
SRP and SR [45^47]. An attractive model would not require
the hydrophobic signal to completely dissociate from SRP
into the aqueous milieu before rebinding to the interaction
site in the translocon. Instead, docking of SRP to its receptor
might optimally position it relative to the translocon to allow
the signal to shift into the translocon site on a ‘greasy slide’
(possibly facilitated by a conformational change in SRP54
upon GTP hydrolysis). The signal will thus insert head-on,
generating an Nexo/Ccyt orientation (Fig. 4, right branch).
Yet, a positive N-terminal £anking sequence will interact
with negative charges at the cytosolic surface of the translo-
con, either on proteins or on lipids, and tend to anchor the N-
terminus of the signal on the cytosolic side and force the
signal to invert its orientation and form a translocation loop
(Fig. 4, left branch). This might occur in a hydrophobic cleft
between translocon subunits and involve lipids, in agreement
with cross-linking data, or it might require partial dissociation
into the polar environment of the translocon pore. In either
case, it is plausible that short, less hydrophobic, or unstable
helices will reorient more readily in response to a positive
charge di¡erence v(N3C) than long, more hydrophobic,
and stable helices. Similarly, an N-terminal extension, partic-
ularly if already folded, will favor or require inversion of the
signal to an Ncyt/Cexo orientation.
Fig. 3. Models of Val19 and Trp19 K-helices. Both sequences e⁄-
ciently target the nascent protein to the ER and behave identically
with respect to topogenesis in vivo [36].
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2.5. Kinetics of targeting and translocation
SRP binding to the signal sequence was shown in vitro to
reduce the elongation rate of the nascent chain^ribosome
complex until its productive docking to the ER membrane
[48^50]. Evidence for a physiological role of this inhibition
has recently been reported in yeast expressing an SRP mutant
defective in slowing elongation [50]. Tight coupling of the
protein’s translation to its transfer through the translocon
ensures translocation competence of the sequences C-terminal
of the signal. In contrast, N-terminal domains of type III
proteins are already completed by the time the signal emerges
from the ribosome and are at risk to fold or misfold still in the
cytosol. The kinetics of SRP binding, targeting to the ER
membrane, and translocation are thus particularly relevant
for type III proteins.
A model type III protein with an N-terminal consensus se-
quence for phosphorylation by protein kinase A was used to
determine these kinetics in vivo in transfected COS cells [51].
Phosphorylation and thus labeling with [32P]phosphate is re-
stricted to the time the phosphorylation site is exposed to the
cytosol: from when it emerges from the ribosome until the
signal does, plus the time it takes to bind SRP to the signal
and to target the complex to the ER membrane, plus the time
required to translocate the N-terminal domain across the
membrane. Increasing the time of cytosolic exposure by ex-
tending the N-terminal domain or by reducing the rate of
translation with cycloheximide increased the speci¢c phos-
phorylation per newly synthesized protein, indicating that
the speci¢c phosphorylation acts as a molecular timer. For
the model protein used (with a hydrophobic core of 25 leucine
residues), the average time of SRP binding and targeting was
determined to amount to only a few seconds (2^5 s). At a
normal elongation rate of V5 amino acids/s [52], this
amounts to a maximum (i.e. in the absence of any translation
slowdown) of 10^25 residues. This does not exclude an im-
portant role for an SRP-induced translation slowdown, since
targeting of the ¢rst ribosome on an mRNA may take signi¢-
cantly longer than that of the subsequent ribosomes in a poly-
some that is already tethered to the ER membrane. Further-
more, these experiments allowed to estimate the rate of
translocation of the N-terminal sequence to be V8 amino
acids/s, i.e. approx. 1.6 times the rate of translation.
3. Topogenesis of multi-spanning membrane proteins
3.1. Topogenic determinants are present throughout the
polypeptide
For complex membrane proteins, which span the bilayer
multiple times, it is generally assumed that the ¢rst hydro-
phobic sequence is responsible for targeting the nascent pro-
tein to the ER and to initiate translocation and membrane
insertion. Accordingly, these proteins could be classi¢ed as
multi-spanning proteins of type I, II, or III based on whether
the most N-terminal apolar sequence is cleaved by signal pep-
tidase or spans the membrane with an Ncyt/Cexo or Nexo/Ccyt
orientation, respectively [53]. The superfamily of seven-trans-
membrane receptors, for example, consists ofV15% members
with a cleavable signal to translocate what becomes the N-
terminal exoplasmic domain. The other ones are inserted with
a reverse signal-anchor as type III seven-spanning proteins.
(Interestingly, the average size of the N-terminal domain is
V140 residues for the type I members and only V40 amino
Fig. 4. Model for the topogenic e¡ect of the hydrophobic core of the signal. For explanation see text.
Fig. 5. Topogenic determinants can be functional throughout the polypeptide. A: Proteins may insert linearly overriding downstream determi-
nants, if the spacer sequences are su⁄ciently long; e.g. the signal-anchor sequence of the ASGP receptor (left), when repeated four times in a
model polypeptide separated by V100 residues, is inserted with either Ncyt/Cexo or Nexo/Ccyt orientation depending on its relative position in
the protein [55]. B: In natural proteins with short loops between transmembrane segments, mutation of topogenic determinants disturbs topol-
ogy only locally; e.g. charge mutations in Glut1 in the £anking sequences of the ¢rst transmembrane domain (left) [60] or in the eighth loop
(right) [61] only a¡ect insertion of the neighboring transmembrane segments.
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acids for the type III members, probably re£ecting the fold-
ing-related di⁄culties in translocating large N-terminal se-
quences.)
According to the simplest model, the most N-terminal sig-
nal sequence de¢nes its own orientation as well as the orien-
tations of all subsequent transmembrane segments, which will
act alternately as stop-transfer and reinsertion sequences.
They do not require any additional information, but will sim-
ply follow the lead of the ¢rst signal. Evidence for this ‘linear
insertion model’ (initially proposed by Blobel [54]) has been
provided using chimeric proteins with two to four signal-an-
chor sequences separated by 50^200 residues from each other
[55,56]. The even-numbered signal-anchors (normally Ncyt/
Cexo) were indeed forced to insert as stop-transfer sequences
(Nexo/Ccyt ; Fig. 5A).
However, there is also strong evidence against a dominant
role of the ¢rst signal in many membrane proteins. Statisti-
cally, internal transmembrane domains also follow the charge
rules, although less stringently than the most N-terminal ones
[57]. Experimentally, insertion of clusters of positive charges
into short exoplasmic loops of model proteins caused individ-
ual hydrophobic domains not to insert at all (‘frustrated’ to-
pologies) [58], showing that positive charges inside a polytopic
membrane protein can be topogenically active. In bacterial
lactose permease and MalF, deletion of individual mem-
brane-spanning segments did not a¡ect the topology of the
downstream transmembrane domains [59]. For the human
glucose transporter Glut1 with 12 membrane spans, inversion
of the charge di¡erence of the ¢rst one did not alter the topol-
ogy of the rest of the molecule, but prevented insertion of the
second apolar sequence (Fig. 5B, left) [60]. Mutation of the
positive charges in the conserved sequence RXGRR in the
¢rst or fourth cytosolic loop of Glut1 resulted only in a local
perturbation in the membrane topology in which the cytoplas-
mic loop was aberrantly translocated into the exoplasm along
with the two £anking transmembrane segments (Fig. 5B,
right) [61]. These studies showed that multi-spanning proteins
contain functional topogenic information throughout their se-
quence.
3.2. Dynamic reorientation of nascent polypeptides in the
translocon
There is an apparent discrepancy between the early studies
with arti¢cial model proteins, which supported a dominant
role of the most N-terminal signal [55,56], and those with
mostly natural proteins, indicating that the topology is de-
¢ned by multiple dispersed determinants [58^62]. This may
be explained by the relatively long spacers between con£icting
determinants used in the former studies in comparison to the
frequently short loops connecting transmembrane segments.
This was indeed con¢rmed by a systematic analysis using
simple chimeric proteins with two con£icting signal sequences,
a cleavable signal and a signal-anchor (Fig. 6A) [63]. When
the signals were separated by 80 residues or more, linear in-
sertion overriding the topological preference of the second
signal was observed (Fig. 6A, left topology). With shorter
spacers, however, an increasing fraction of proteins inserted
with a translocated C-terminus as dictated by the second sig-
nal (Fig. 6A, right topology). The second signal thus co-de-
termined the insertion process. At an elongation rate of V5
amino acids/s, the second signal will enter the translocon ap-
prox. 16 s after the ¢rst one (60 residues spacer+20 residues of
the signal-anchor, divided by 5 amino acids/s). This indicates
that at least a subset of polypeptides is not committed to a
¢nal topology 16 s after initiation of topogenesis.
In most natural proteins, the contributions of subsequent
determinants add up to a unique topology. Yet, the human
prion protein is an example in which competing signals appear
to be at work similar to the arti¢cial constructs mentioned
above (Fig. 6B) [64]. The prion protein contains a cleavable
signal at the N-terminus and a stop-transfer sequence which is
normally replaced by a glycosylphosphatidylinositol (GPI)-an-
chor at the very C-terminus. In addition there is a hydropho-
bic sequence in the middle of the protein which is mostly
translocated across the membrane, generating the so-called
SecPrP. In a fraction of the products, however, it is integrated
into the bilayer either with an Nexo/Ccyt orientation, as ex-
pected for a stop-transfer sequence, producing NtmPrP, or
with the opposite Ncyt/Cexo orientation, producing CtmPrP.
Natural and arti¢cial mutants in or near the internal hydro-
phobic sequence and the N-terminal signal are known which
increase the fraction of CtmPrP [64].
It is obvious that two hydrophobic sequences with a very
short spacer cannot orient themselves independently of each
other during topogenesis, since they will insert together as a
hairpin. With an increasing distance the cooperativity (or the
competition) of successive transmembrane elements decreases
and ¢nally disappears. In the case of contradictory determi-
nants, the polypeptide segment translocated by the ¢rst signal
will have to be retranslocated to the cytosolic side when the
second signal enters the translocon and exerts its topogenic
preference. This was con¢rmed by insertion of an N-glycosyl-
ation site into the spacer sequence between the two con£icting
signals illustrated in Fig. 6A [63]. Glycosylation signi¢cantly
Fig. 6. Competition between topogenic determinants. A: Combina-
tion of a cleavable signal with a signal-anchor sequence generated
two di¡erent topologies [63]. Spacer sequences of 80 or more resi-
dues produced exclusively the type I membrane protein on the left.
Shorter spacers yielded an increasing fraction of the topology on
the right. Glycosylation in the loop (indicated by an asterisk) shifted
the equilibrium to the left. B: Topologies of the prion protein. Sig-
nal cleavage is indicated by an arrowhead.
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shifted the equilibrium of topologies in favor of that with a
translocated spacer sequence, most likely by sterically trap-
ping it in the ER lumen. This demonstrates that polypeptides
of up to 60 residues in length can dynamically reorient within
the translocon and that glycosylation can co-determine pro-
tein topology.
4. Conclusion
Protein topogenesis appears to be directed by multiple de-
terminants which in unlimited combinations add up to an
almost uniform result for most, but not all, natural proteins.
With what is known up to now, it is still impossible, certainly
in the case of complex membrane proteins, to con¢dently
predict topology from sequence or to design membrane pro-
teins de novo. During protein targeting, translocation, and
insertion into the membrane, several processes occur simulta-
neously and in£uence each other. Modi¢cations like glycosyl-
ation, but potentially also signal cleavage and protein folding,
may stabilize particular topologies. Furthermore, relatively
large segments can move back and forth through the trans-
location pore in search for the most comfortable position of
the polypeptide in the translocon and the membrane. Protein
insertion is thus in unexpected ways a very dynamic process.
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